Note: Ingredients listed on restricted chemical lists
EC/CAS
78-44-4
Name of the chemical
Carisoprodol (INN)
Concentration
N/A
EC/CAS
9005-25-8
Name of the chemical
Starch
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
General Information
Revision date
2015-12-05
Product name
Carisoprodol Tablets, USP 350 mg
Chemical name
N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate
Manufacturer Name
ScieGen Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
ScieGen Pharmaceuticals, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 OSHA hazard(s) Not classified.
Signal word
Warning
Hazard statements
May form combustible dust concentrations in air. H302 - Harmful if swallowed
Precautionary statements
P264 - Wash hands, forearms, and other exposed areas thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P301+P312 - If swallowed: Call a poison center or doctor if you feel unwell. P330 - Rinse mouth. P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations.
2.3 Other hazards
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. Most common adverse reactions are drowsiness, dizziness, and headache.
Ingredient(s) with unknown acute toxicity
No data available
